197 related articles for article (PubMed ID: 22300618)
1. Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Gruhn B; Klöppner N; Pfaffendorf-Regler N; Beck J; Zintl F; Bartholomä S; Debatin KM; Steinbach D
Biol Blood Marrow Transplant; 2012 Jun; 18(6):958-63. PubMed ID: 22300618
[TBL] [Abstract][Full Text] [Related]
2. Re: Toll-like 4 receptor variant, Asp299Gly, and reduced risk of hemorrhagic cystitis after hematopoietic stem cell transplantation.
Schaeffer EM
J Urol; 2013 Dec; 190(6):2103. PubMed ID: 24209529
[No Abstract] [Full Text] [Related]
3. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation.
Gorczynska E; Turkiewicz D; Rybka K; Toporski J; Kalwak K; Dyla A; Szczyra Z; Chybicka A
Biol Blood Marrow Transplant; 2005 Oct; 11(10):797-804. PubMed ID: 16182180
[TBL] [Abstract][Full Text] [Related]
4. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
Elmaagacli AH; Koldehoff M; Hindahl H; Steckel NK; Trenschel R; Peceny R; Ottinger H; Rath PM; Ross RS; Roggendorf M; Grosse-Wilde H; Beelen DW
Transplantation; 2006 Jan; 81(2):247-54. PubMed ID: 16436969
[TBL] [Abstract][Full Text] [Related]
5. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.
Kondo M; Kojima S; Kato K; Matsuyama T
Bone Marrow Transplant; 1998 Nov; 22(10):995-8. PubMed ID: 9849697
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study.
Mensah NY; Peterlongo P; Steinherz P; Pamer EG; Satagopan J; Papanicolaou GA
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1130-3. PubMed ID: 19660727
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation.
Cheuk DK; Lee TL; Chiang AK; Ha SY; Lau YL; Chan GC
Transpl Int; 2007 Jan; 20(1):73-81. PubMed ID: 17181656
[TBL] [Abstract][Full Text] [Related]
10. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST).
Yamamoto R; Kusumi E; Kami M; Yuji K; Hamaki T; Saito A; Murasgihe N; Hori A; Kim SW; Makimoto A; Ueyama J; Tanosaki R; Miyakoshi S; Mori S; Morinaga S; Heike Y; Taniguchi S; Masuo S; Takaue Y; Mutou Y
Bone Marrow Transplant; 2003 Dec; 32(11):1089-95. PubMed ID: 14625581
[TBL] [Abstract][Full Text] [Related]
11. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group.
Cesaro S; Brugiolo A; Faraci M; Uderzo C; Rondelli R; Favre C; Zecca M; Garetto G; Dini G; Pillon M; Messina C; Zanesco L; Pession A; Locatelli F
Bone Marrow Transplant; 2003 Nov; 32(9):925-31. PubMed ID: 14561994
[TBL] [Abstract][Full Text] [Related]
12. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir.
Gaziev J; Paba P; Miano R; Germani S; Sodani P; Bove P; Perno CF; Marziali M; Gallucci C; Isgrò A; Paciaroni K; Roveda A; Simone MD; De Angelis G; Alfieri C; Lucarelli G
Biol Blood Marrow Transplant; 2010 May; 16(5):662-71. PubMed ID: 20026413
[TBL] [Abstract][Full Text] [Related]
13. [Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation].
Ma XJ; Ren HY; Qiu ZX; Cen XN; Ou JP; Wang WS; Xu WL; Wang LH; Dong YJ; Sun YH; Li Y; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1007-12. PubMed ID: 20723318
[TBL] [Abstract][Full Text] [Related]
14. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.
Carvalho A; Cunha C; Carotti A; Aloisi T; Guarrera O; Di Ianni M; Falzetti F; Bistoni F; Aversa F; Pitzurra L; Rodrigues F; Romani L
Exp Hematol; 2009 Sep; 37(9):1022-9. PubMed ID: 19539691
[TBL] [Abstract][Full Text] [Related]
16. Impact of Toll-like receptor 4 polymorphisms on risk of cancer.
Kutikhin AG
Hum Immunol; 2011 Feb; 72(2):193-206. PubMed ID: 21081146
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.
Silva Lde P; Patah PA; Saliba RM; Szewczyk NA; Gilman L; Neumann J; Han XY; Tarrand J; Ribeiro R; Gulbis A; Shpall EJ; Jones R; Popat U; Walker JA; Petropoulos D; Chiattone A; Stewart J; El-Zimaity M; Anderlini P; Giralt S; Champlin RE; de Lima M
Haematologica; 2010 Jul; 95(7):1183-90. PubMed ID: 20410183
[TBL] [Abstract][Full Text] [Related]
18. Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation.
Asano Y; Kanda Y; Ogawa N; Sakata-Yanagimoto M; Nakagawa M; Kawazu M; Goyama S; Kandabashi K; Izutsu K; Imai Y; Hangaishi A; Kurokawa M; Tsujino S; Ogawa S; Aoki K; Chiba S; Motokura T; Hirai H
Bone Marrow Transplant; 2003 Dec; 32(12):1175-9. PubMed ID: 14647272
[TBL] [Abstract][Full Text] [Related]
19. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer.
Davoodi H; Seow HF
Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):91-9. PubMed ID: 21625017
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
